Keyword: Abbott Laboratories
Rep. Dave Trott, R-Mich., is backing a bill that would create voluntary guidelines for medical device cybersecurity, contrasting a more rigorous Senate bill.
More clarity from the FDA and a formal process for quantifying adverse events associated with the firmware update will improve device recalls.
The agency's new guidance for medical device manufacturers highlights the importance of consistent data exchange between devices and systems.
The FDA has approved a firmware update for Abbott-manufactured pacemakers that patches cybersecurity vulnerabilities identified a year ago.
Improving patient nutrition can save hospitals a lot of money, according to a new study.
Medical device manufacturers want to develop industrywide cybersecurity standards that would close the risk-benefit gap for connected devices.
Cycling out legacy systems and devices that create cybersecurity vulnerabilities is a difficult task that could benefit from a structured incentive program.
The FDA warned Abbott that it needs to fix the cybersecurity concerns associated with its cardiac devices within 15 days or face further penalties.
Omnicare Inc. has agreed to pay a $28.125 million settlement for its role in a kickback scheme with drug manufacturer Abbott Laboratories.
A look at marketing tactics used by Abbott Laboratories to push OxyContin offers new insight into the company’s business practices and the way it escaped legal scrutiny.